2020;105(4):e1056e1063
Cells were treated with various concentrations of URB597 or 4-(3-chloro-2-pyridinyl)-N-[4-(1,1-dimethylethyl)phenyl]-1-piperazinecarboxamide (BCTC) (0.02, 0.5, 2 mol/L, Cayman Chemical Company, Ann Arbor, MI, USA), SR144528 (0.02, 0.5, 2 mol/L, EMD Millipore, Etobicoke, ON, Canada), indomethacin (2, 20, 50 mol/L, Sigma-Aldrich, Oakville, ON, Canada), or vehicle solution (0.1% dimethyl sulfoxide, DMSO) and incubated for 15 min at 37 C in 5% CO 2
[DOI] [PMC free article] [PubMed] [Google Scholar] 58.Preen D., Dawson B., Goodman C., Beilby J., Ching S
Always seek advice from your GP or obstetrician before commencing any treatment
We found that supplementation with L-GSH for three months was able to reduce the levels of MDA in all blood components, including plasma ( Figure 4C ), PBMCs ( Figure 4D ), and RBCs ( Figure 4E )